| Bosutinib |
ENSG00000118412.8 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000118412.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000125804.9 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000125804.9 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000131484.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000131484.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000152487.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000157306.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000160336.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000170161.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000170161.6 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000171889.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000172965.10 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000172965.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000175701.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000175873.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000175873.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000177788.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000177853.10 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000177993.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000178248.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000178440.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000178947.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000179219.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000179406.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000179859.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000180139.10 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000180279.5 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000180846.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000181800.5 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000182165.13 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000182165.13 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000182873.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000184068.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000184068.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000184274.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000184856.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000185186.4 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000185495.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000185904.7 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000186019.10 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000186615.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000187621.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000187979.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000189229.10 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000196273.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000196559.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000196668.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000197291.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000197813.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000197934.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000197989.9 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000203258.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000203279.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000203280.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000203288.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000203327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000203327.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000203356.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000203362.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000203441.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000203441.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000203496.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000203588.3 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000203588.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000203645.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000203650.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000203650.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000203688.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000203729.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000203801.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000203875.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000203875.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000203999.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000204241.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000204380.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000204380.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000204625.6 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000204666.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000204706.10 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000204802.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000204837.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000204860.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000205181.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000205424.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000205622.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000205662.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000205662.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000205663.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000206028.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000206028.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000206028.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000206129.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000206140.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000206142.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000206176.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000206417.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000206417.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000212552.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000212694.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000212694.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000212978.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000213742.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000214146.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000214293.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000214347.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000214650.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000214650.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000214770.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000214803.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000214851.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000214870.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000214894.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000214894.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000215039.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000215159.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000215417.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000215458.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000215692.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000215769.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000215841.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000215863.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000217258.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000221571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000222041.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000222041.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000223356.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000223374.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000223392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000223414.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000223461.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000223461.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000223462.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000223473.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000223477.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000223477.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000223561.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000223571.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000223573.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000223598.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000223695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000223701.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000223714.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000223749.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000223764.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000223784.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000223804.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000223834.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000223882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000223923.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000224031.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000224043.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000224043.3 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000224057.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000224086.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000224086.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000224142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000224142.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000224157.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000224157.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000224189.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000224189.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000224238.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000224271.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000224292.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000224358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000224481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000224505.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000224511.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000224511.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000224565.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000224596.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000224614.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000224614.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000224623.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000224623.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000224635.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000224638.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000224655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000224655.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000224707.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000224738.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000224738.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000224746.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000224804.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000224805.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000224818.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000224821.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000224846.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000224863.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000224884.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000224885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000224888.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000224932.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000224934.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000224959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000224969.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000224969.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000224975.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000225063.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000225075.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000225083.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000225087.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000225140.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000225140.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000225173.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000225187.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000225205.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000225218.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000225234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225234.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000225235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000225235.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000225265.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000225278.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225331.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000225383.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225439.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000225484.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000225493.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000225506.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000225528.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225541.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000225548.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000225559.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225675.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000225703.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000225744.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000225783.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000225783.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000225783.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225783.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000225792.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225792.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000225806.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000225815.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225822.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000225850.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000225872.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225880.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000225889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225891.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000225891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225945.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000225953.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000225981.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000226047.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000226051.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000226137.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000226155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000226194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000226200.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000226200.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000226291.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000226310.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000226312.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000226312.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000226330.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000226330.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000226349.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000226349.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000226349.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000226352.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000226352.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000226363.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000226363.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000226375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000226380.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000226381.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000226416.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000226445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000226445.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000226453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000226476.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000226505.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000226505.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000226520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000226526.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000226562.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000226562.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000226574.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000226648.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000226676.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000226754.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000226798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000226803.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000226816.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000226819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000226833.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000226835.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000226842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000226851.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000226852.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000226852.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000226856.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000226862.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000226869.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000226876.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000226944.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000226954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000226957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000226969.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000227006.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000227014.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000227017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227071.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000227082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000227082.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000227094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227110.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000227161.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000227165.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000227188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227200.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000227218.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000227220.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227252.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000227252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227297.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000227354.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000227355.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227403.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000227407.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000227409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000227438.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000227484.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227492.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000227492.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000227495.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000227496.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000227496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227512.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000227527.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000227542.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000227589.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000227627.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000227637.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000227637.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000227640.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227640.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000227673.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000227676.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000227678.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000227704.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000227726.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000227740.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000227773.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000227773.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000227857.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000227885.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000227888.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000227945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000228037.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000228043.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000228079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228107.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000228107.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000228108.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000228141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228150.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000228172.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000228201.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000228203.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000228221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000228223.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000228271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228274.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000228274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228288.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000228293.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000228317.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000228352.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000228358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228382.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228386.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000228386.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000228386.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000228397.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000228412.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000228444.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000228444.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000228452.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000228463.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000228470.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000228470.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000228485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228486.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000228487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228506.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000228509.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000228540.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000228544.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228614.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000228624.3 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000228624.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000228634.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000228649.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228677.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000228697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228707.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228737.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000228763.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000228775.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228775.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000228784.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000228784.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000228798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000228801.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000228802.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000228839.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000228878.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000228886.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000228886.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000228917.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000228939.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000228956.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000228972.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000228973.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000229017.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000229021.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000229122.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000229124.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000229127.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229312.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229348.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000229368.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000229463.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229463.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000229502.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229582.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000229582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229589.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000229591.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000229591.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000229591.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000229645.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000229697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229702.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000229727.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229728.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000229739.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000229766.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229780.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000229780.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000229832.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000229832.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000229832.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000229839.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000229839.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000229873.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000229891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229950.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000229951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229952.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000229952.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000229970.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000229996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000229999.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000230010.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000230020.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000230061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000230068.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000230068.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000230074.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000230102.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000230102.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000230105.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000230109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000230131.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000230174.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000230289.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000230303.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000230310.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000230333.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000230368.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000230424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000230424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000230427.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000230433.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000230439.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000230461.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000230470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000230489.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000230499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000230523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000230530.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000230537.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000230550.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000230597.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000230615.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000230633.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000230679.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000230753.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000230789.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000230806.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000230815.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000230825.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000230825.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000230838.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000230844.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000230896.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000230910.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000230912.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000230925.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000230937.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000231010.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000231024.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000231028.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000231050.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000231050.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000231054.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000231056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000231079.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000231081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000231104.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000231121.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000231196.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000231212.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000231233.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000231242.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000231295.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000231297.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000231305.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000231305.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000231355.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000231367.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000231407.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000231407.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000231465.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000231481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000231528.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000231563.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000231566.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000231595.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000231595.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000231607.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000231628.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000231651.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000231654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000231690.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000231691.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000231703.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000231704.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000231709.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000231711.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000231713.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000231731.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000231731.3 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000231734.4 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000231742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000231760.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000231816.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000231898.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000231966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000231976.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000231976.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000232023.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000232046.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232082.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000232093.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000232104.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000232118.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000232160.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000232164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232192.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232233.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000232298.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000232300.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232325.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232342.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000232388.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000232412.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000232445.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000232461.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000232480.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000232487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000232527.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000232527.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000232533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232613.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000232613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000232623.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232640.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000232640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232645.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232645.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000232692.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000232698.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000232719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000232721.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000232784.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232788.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000232788.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000232788.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000232803.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000232860.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000232936.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000232940.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000232956.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000232969.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000232978.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000233013.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000233016.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000233033.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000233038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233077.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000233178.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000233178.3 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000233184.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000233215.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000233223.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000233237.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233251.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233293.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000233303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233330.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000233330.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000233339.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233351.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000233363.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000233367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233384.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000233427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233429.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000233452.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000233452.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000233478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233501.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000233547.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000233602.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000233613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233635.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000233642.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233654.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000233723.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000233757.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000233775.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000233785.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000233799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000233799.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000233799.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000233800.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233806.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000233806.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233834.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000233847.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000233854.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000233860.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000233862.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000233885.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000233893.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000233895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000233903.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000233942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000234006.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000234006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000234070.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000234072.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000234129.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000234134.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000234141.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000234197.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000234206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000234208.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000234225.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000234245.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000234263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000234281.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000234286.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000234327.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000234352.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000234384.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000234393.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000234393.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000234405.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000234449.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000234456.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000234476.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000234477.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000234492.4 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000234494.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000234509.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000234567.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000234572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000234617.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000234630.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000234678.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000234678.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000234684.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000234689.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000234690.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000234694.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000234695.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000234715.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000234722.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000234740.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000234772.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000234793.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000234818.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000234902.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000234913.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000234915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000234917.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000234917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000234928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000234943.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000234945.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000234945.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000234978.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000234996.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000234997.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000234998.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000235024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235029.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235033.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000235052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000235070.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235072.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000235072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235078.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000235078.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000235092.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000235106.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000235106.4 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000235119.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000235121.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000235121.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235123.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000235192.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000235204.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000235214.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000235257.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000235262.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000235271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235335.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000235366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235373.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000235373.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000235381.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000235423.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000235423.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000235427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235445.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000235481.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000235488.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000235522.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000235529.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000235560.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000235586.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000235609.4 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000235643.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000235659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235664.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000235669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235706.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000235724.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000235726.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000235760.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000235770.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000235781.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000235790.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000235795.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000235831.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000235843.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000235843.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000235848.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000235884.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000235897.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000235908.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000235919.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000235927.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235979.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000235989.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000236003.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000236051.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000236066.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000236088.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000236116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000236137.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000236194.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000236199.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000236200.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000236200.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000236206.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000236206.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000236209.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000236212.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000236269.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000236269.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000236308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000236336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000236358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000236366.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000236383.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000236394.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000236463.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000236472.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000236472.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000236507.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000236519.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000236540.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000236545.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000236558.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000236558.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000236617.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000236618.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000236618.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000236643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000236651.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000236703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000236708.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000236711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000236743.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000236751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000236751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000236772.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000236772.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000236772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000236790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000236824.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000236861.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000236908.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000236914.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000236953.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000236986.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000236991.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000237017.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000237054.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000237054.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000237073.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000237149.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000237152.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237152.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000237159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237234.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000237291.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000237298.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000237310.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000237328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237331.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000237343.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000237380.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000237399.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000237404.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000237424.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000237461.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000237481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237484.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237489.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000237523.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000237576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000237594.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237605.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000237640.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000237658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237686.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000237686.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000237714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237726.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000237737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000237753.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000237753.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000237756.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000237773.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000237786.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000237813.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237813.3 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000237819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237852.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000237870.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237883.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000237886.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000237899.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000237903.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000237903.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000237927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237937.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237940.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000237940.3 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000237976.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000237989.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000238009.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000238039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000238113.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000238113.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000238120.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000238123.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000238140.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000238140.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000238141.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000238186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000238197.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000238197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000238198.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000238221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000238221.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000238266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000238279.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000238755.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000239219.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000239219.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000239407.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000239415.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000239498.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000239593.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000239664.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000239674.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000239705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000239801.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000239906.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000239906.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000239945.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000240005.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000240006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000240015.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000240057.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000240093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000240143.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000240207.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000240291.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000240291.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000240291.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000240401.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000240423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000240440.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000240440.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000240571.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000240591.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000240591.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000240618.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000240758.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000240770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000240922.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000240996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000241042.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000241135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000241211.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000241288.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000241359.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000241570.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000241599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000241770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000241860.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000241886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000241912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000241933.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000242136.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000242147.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000242147.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000242391.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000242474.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000242516.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000242540.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000242553.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000242622.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000242759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000242770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000242797.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000243176.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000243220.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000243224.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000243230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000243321.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000243368.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000243479.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000243479.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000243636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000243637.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000243701.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000243795.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000243810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000243926.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000243960.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000244124.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000244124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000244137.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000244158.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000244184.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000244203.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000244268.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000244300.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000244300.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000244380.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000244383.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000244513.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000244578.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000244586.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000244625.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000244625.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000244625.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000244945.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000244968.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000244968.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000245059.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000245060.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000245213.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000245275.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000245384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000245498.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000245522.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000245534.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000245534.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000245556.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000245573.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000245648.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000245667.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000245711.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000245812.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000245849.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000245870.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000245904.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000245928.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000245954.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000246089.3 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000246089.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000246090.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000246090.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000246130.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000246130.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000246225.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000246250.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000246273.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000246323.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000246339.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000246422.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000246430.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000246465.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000246465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000246523.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000246526.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000246528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000246560.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000246662.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000246731.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000246731.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000246740.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000246790.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000246790.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000246792.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000246851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000246859.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000246889.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000246889.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000246898.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000246898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000246898.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000247092.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000247137.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000247151.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000247240.3 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000247287.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000247363.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000247373.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000247400.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000247416.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000247516.3 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000247572.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000247595.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000247595.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000247679.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000247828.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000247877.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000247934.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000247934.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000247982.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000248027.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000248092.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000248125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000248131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000248161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000248206.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000248240.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000248245.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000248268.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000248275.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000248356.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000248367.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000248416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000248416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000248445.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000248445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000248508.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000248528.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000248554.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000248554.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000248559.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000248559.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000248664.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000248668.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000248677.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000248714.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000248714.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000248734.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000248783.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000248790.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000248846.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000248896.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000248925.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000248925.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000248936.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000249042.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000249131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000249167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000249231.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000249234.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000249234.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000249241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000249249.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000249307.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000249345.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000249364.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000249417.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000249456.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000249476.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000249483.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000249492.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000249574.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000249593.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000249593.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000249610.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000249650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000249650.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000249664.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000249685.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000249685.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000249717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000249786.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000249859.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000249885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000249896.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000249898.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000250001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000250012.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000250015.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000250033.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000250043.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000250049.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000250057.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000250061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000250081.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000250106.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000250107.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000250122.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000250132.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000250220.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000250240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000250271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000250286.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000250312.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000250328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000250337.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000250413.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000250421.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000250508.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000250508.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000250519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000250522.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000250579.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000250596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000250614.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000250616.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000250659.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000250682.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000250682.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000250699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000250734.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000250751.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000250764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000250764.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000250764.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000250786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000250786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000250786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000250802.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000250802.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000250882.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000250909.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000250920.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000250950.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000250950.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000250958.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000250961.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251003.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000251015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251018.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000251026.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000251026.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000251031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251131.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000251148.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000251151.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000251175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251194.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000251216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251279.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000251292.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251301.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000251323.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000251323.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000251323.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000251363.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000251387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251432.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000251442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251577.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000251584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000251613.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000251620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000251687.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000251687.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000253121.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000253174.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000253222.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000253266.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000253307.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000253317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000253327.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000253347.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000253355.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000253374.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000253392.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000253392.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000253438.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000253445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000253477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000253549.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000253552.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000253552.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000253562.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000253591.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000253618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000253636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000253636.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000253706.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000253708.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000253712.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000253730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000253741.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000253744.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000253784.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000253832.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000253844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000253921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000253931.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000253955.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000253972.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000253973.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000254002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254039.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000254044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000254144.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000254153.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000254205.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000254207.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000254207.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000254208.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000254224.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000254266.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000254271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254286.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000254286.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000254315.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000254340.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000254347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254370.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000254389.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000254418.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000254427.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000254433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000254458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254459.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254484.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000254484.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254495.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000254526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254538.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000254539.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000254551.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000254554.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000254557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254615.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000254615.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000254620.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000254731.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000254731.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000254774.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000254777.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000254791.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000254846.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254854.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000254864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000254900.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000254907.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000254951.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000254966.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000254968.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000254972.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000254985.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000254985.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000254987.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000255008.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000255031.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000255125.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000255145.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000255148.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000255160.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000255191.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000255234.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000255237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000255299.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000255299.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000255310.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000255314.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000255318.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000255334.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000255337.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000255375.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000255421.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000255435.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000255449.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000255456.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000255467.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000255471.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000255476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000255495.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000255503.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000255507.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000255507.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000255580.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000255650.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000255651.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000255651.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000255669.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000255670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000255672.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000255689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000255717.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000255794.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000255843.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000255893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000255966.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000255983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000256006.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000256006.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000256006.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000256006.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000256011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000256025.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000256092.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000256116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000256124.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000256146.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000256146.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000256150.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000256237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000256268.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000256299.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000256312.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000256312.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000256360.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000256417.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000256417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000256443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000256448.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000256458.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000256564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000256576.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000256576.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000256588.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000256603.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000256746.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000256747.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000256789.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000256862.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000256982.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000256984.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257004.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000257023.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000257023.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257027.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000257052.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000257058.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000257058.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000257060.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000257084.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000257261.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000257264.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000257264.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000257303.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000257329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000257354.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000257366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257381.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000257381.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000257381.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000257391.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257398.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257433.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000257475.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000257475.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000257499.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000257499.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257526.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000257527.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000257563.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257605.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000257613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257636.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000257696.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257702.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000257702.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000257735.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000257742.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000257759.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000257769.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257808.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000257809.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000257894.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000257894.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000257931.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000257964.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000257964.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000257999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258044.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000258057.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000258086.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258086.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000258088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258099.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000258099.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000258099.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000258101.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000258123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258317.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258323.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000258345.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000258345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258354.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258378.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258412.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258412.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000258413.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000258413.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000258424.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000258424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258428.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258428.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000258441.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258442.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000258443.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000258443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258449.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000258450.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000258454.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258479.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258553.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258580.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258593.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000258602.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000258693.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000258704.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000258730.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000258752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258798.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000258803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258815.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258821.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000258821.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000258857.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000258904.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000258914.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000258929.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000258929.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258940.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000258940.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000258946.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000258952.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000258957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000258983.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000258983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000259002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000259005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000259036.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259039.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000259039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259073.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259084.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259087.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000259087.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000259107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259125.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000259125.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000259129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259146.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259153.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000259172.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000259187.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000259198.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000259209.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000259212.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000259230.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000259230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000259241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259248.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000259251.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259264.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259298.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000259306.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259306.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000259327.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000259341.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259345.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000259349.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000259351.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259364.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000259364.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000259370.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259380.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000259380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259380.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000259398.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000259416.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000259418.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000259424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000259426.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000259462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259469.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000259475.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000259483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259514.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000259515.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000259577.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000259579.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000259584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000259594.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259595.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000259598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259606.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000259623.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000259623.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000259628.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000259652.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000259666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259687.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000259692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259717.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000259717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259736.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000259744.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000259757.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000259768.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000259771.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000259782.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000259783.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000259802.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000259804.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000259806.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000259807.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000259818.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000259828.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000259828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259840.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000259840.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259883.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000259886.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000259891.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000259915.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000259935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000259943.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000260005.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000260005.2 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000260005.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000260008.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000260008.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000260018.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000260018.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000260021.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260037.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000260059.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000260060.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000260060.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000260060.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000260063.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000260086.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000260091.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000260095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000260095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260101.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000260118.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000260136.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000260136.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000260141.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000260167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000260167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260177.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000260193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000260209.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000260249.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000260265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260285.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000260288.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000260293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260296.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000260296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260306.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000260316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260352.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000260352.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000260360.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000260367.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000260368.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000260388.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000260394.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000260396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260396.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260403.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260409.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000260418.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260455.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000260468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260475.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000260488.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000260515.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000260515.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000260517.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260517.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000260526.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000260563.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000260565.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260572.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000260572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260585.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260589.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000260604.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000260608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260618.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000260625.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000260643.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000260645.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000260646.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260646.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000260647.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000260651.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000260655.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000260655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260661.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260664.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000260664.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000260672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000260708.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000260708.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000260743.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000260750.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000260766.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000260777.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000260790.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000260793.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260796.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000260808.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000260808.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000260814.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000260831.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000260841.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000260871.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000260871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260874.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000260874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260884.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000260905.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000260920.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000260923.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000260924.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000260930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260932.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000260941.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000260948.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000260949.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000260954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000260954.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000260955.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000260976.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000260988.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000260989.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000260997.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000261000.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000261008.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000261019.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000261024.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000261033.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000261064.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000261083.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000261096.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000261131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000261140.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000261140.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000261172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000261183.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000261188.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000261195.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261216.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000261231.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000261242.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000261248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261252.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000261254.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000261265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261266.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000261267.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000261291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000261318.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000261326.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000261329.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000261334.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000261334.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000261353.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000261355.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000261357.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000261357.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000261360.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000261386.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000261396.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000261399.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000261407.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000261416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261428.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000261430.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000261431.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261471.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261474.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000261496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261504.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000261505.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000261529.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000261533.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000261534.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000261543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261574.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000261589.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000261592.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000261596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261613.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000261633.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000261656.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000261662.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000261669.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000261685.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000261692.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000261695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000261695.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000261712.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000261713.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261720.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261729.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000261737.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000261758.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000261761.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000261766.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000261775.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000261780.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000261823.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000261840.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000261842.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000261864.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000261879.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000261879.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000261888.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000261889.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000261916.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000261996.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000262097.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000262098.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000262098.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000262136.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000262155.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000262171.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000262223.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000262265.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000262294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000262339.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000262339.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000262380.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000262380.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000262380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000262410.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000262454.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000262558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000262721.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000262768.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000262772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000262777.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000262777.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000262837.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000262877.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000262877.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000262999.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000263051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000263063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000263080.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000263105.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000263164.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000263214.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000263214.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000263272.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000263345.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000263370.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000263499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000263603.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000263603.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000263603.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000263627.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000263657.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000263786.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000263884.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000263916.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000263923.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000263924.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000263931.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000263934.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000264015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000264043.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000264083.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000264107.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000264151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000264167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000264207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000264222.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000264270.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000264448.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000264448.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000264458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000264520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000264520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000264548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000264575.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000264729.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000264808.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000264860.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000264885.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000264920.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000264932.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000264940.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000264940.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000265008.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000265094.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000265142.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000265222.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000265222.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000265282.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000265342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000265342.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000265349.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000265349.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000265394.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000265399.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000265451.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000265496.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000265511.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000265511.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000265625.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000265749.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000265752.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000265778.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000265778.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000265791.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000265791.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000265845.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000265908.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000265943.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000265971.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000266049.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000266100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000266120.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000266126.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000266236.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000266256.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000266278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000266289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000266289.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000266304.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000266312.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000266340.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000266371.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000266402.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000266446.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000266473.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000266579.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000266598.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000266601.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000266601.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000266651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000266709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000266801.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000266803.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000266821.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000266821.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000266844.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000266900.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000266903.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000266904.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000266912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000266912.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000266918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000266921.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000266927.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000266935.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000266935.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000266941.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000266942.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000266957.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000266965.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000266994.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000266994.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000267010.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000267011.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000267018.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000267018.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000267058.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000267063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000267064.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000267080.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000267093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267128.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000267141.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000267150.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000267151.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000267161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267167.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000267167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267169.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000267183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000267183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000267194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267221.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000267230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000267230.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000267244.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000267251.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000267263.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000267272.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000267274.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000267288.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000267289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000267317.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000267321.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000267322.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000267344.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000267348.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000267348.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267348.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000267374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267381.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000267390.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000267394.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000267395.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000267397.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000267414.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000267419.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000267421.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000267480.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000267481.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000267498.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000267501.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000267557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267560.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000267560.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000267565.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000267565.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000267575.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000267581.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000267583.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000267605.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000267606.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000267649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267655.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000267659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267667.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267690.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000267715.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000267731.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000267747.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000267747.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000267747.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000267751.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000267764.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000267783.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000267787.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000267787.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000267798.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000267898.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000267940.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000268001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000268015.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000268047.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000268061.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000268061.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000268093.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000268095.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000268230.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000268307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000268375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000268392.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000268460.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000268564.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000268568.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000268573.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000268583.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000268583.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000268649.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000268836.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000268895.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000268912.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000268947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000268970.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000268970.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000269019.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269066.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000269086.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269086.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000269148.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000269194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269235.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000269235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000269293.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000269356.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000269386.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000269386.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000269463.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000269463.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000269487.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000269489.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269534.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000269574.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000269609.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000269652.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000269652.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269696.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000269707.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000269729.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000269737.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000269752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269825.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000269825.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000269834.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000269836.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000269843.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269867.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000269873.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269892.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000269894.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000269901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000269903.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000269906.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000269911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269921.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000269924.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000269924.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000269927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269938.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000269942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269942.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000269946.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000269947.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000269951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269954.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000269954.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000269956.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000269966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269976.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000269978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000269985.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000269990.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000269994.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000270000.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000270006.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000270010.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000270015.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000270019.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000270020.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000270022.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000270035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000270036.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000270039.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000270041.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000270049.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000270061.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000270062.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000270067.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000270068.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000270068.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000270068.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000270076.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000270081.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000270083.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000270083.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000270090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000270091.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000270093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000270095.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000270100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000270100.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000270104.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000270108.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000270109.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000270117.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000270124.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000270133.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000270133.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000270140.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000270154.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000270157.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000270159.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000270159.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000270165.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000270170.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000270189.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000270189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000270189.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000270195.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000270237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000270265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000270361.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000270462.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000270557.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000270562.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000270571.2 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000270589.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000270599.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000270640.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000270659.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000270673.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000270697.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000270755.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000270820.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000270988.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000271086.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000271109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271151.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000271200.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000271204.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000271234.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271270.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000271314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271335.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000271366.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000271384.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000271387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271398.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000271551.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271590.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000271590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271717.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000271722.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000271732.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000271732.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271755.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000271757.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271781.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000271789.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000271803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271821.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000271826.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000271826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271835.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000271840.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000271840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000271843.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000271845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271849.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000271851.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000271855.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000271856.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000271862.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000271871.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000271888.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000271914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271963.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000271963.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000271966.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000271966.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000271967.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000271992.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000271998.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000271998.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272003.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000272009.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000272023.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272024.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000272024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272029.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000272033.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000272033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272040.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000272040.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272048.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272053.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000272057.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000272065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000272070.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000272070.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000272076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272077.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000272081.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000272086.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272087.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000272091.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000272091.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000272093.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000272097.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000272123.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000272128.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000272167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272168.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000272172.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000272172.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000272183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000272198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000272216.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000272216.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000272233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272248.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000272248.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000272254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272254.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000272255.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000272264.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000272264.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000272265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000272273.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272273.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000272279.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000272288.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000272288.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000272288.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272316.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000272327.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272365.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000272365.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000272366.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000272368.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000272369.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000272369.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000272370.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272374.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000272375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000272377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000272377.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000272377.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000272384.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000272389.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272403.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000272403.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272447.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272452.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272506.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272512.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272529.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272558.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272562.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272562.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000272567.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000272567.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000272588.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000272609.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000272622.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000272627.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272632.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272635.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000272662.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000272662.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000272667.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000272672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272682.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000272688.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000272695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272696.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000272699.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000272699.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000272702.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000272707.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000272716.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272754.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000272760.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000272764.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000272784.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272796.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000272823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000272824.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000272828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272829.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000272836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272853.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000272892.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000272905.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000272905.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000272912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000272914.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000272917.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000272931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272933.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000272940.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000272954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272983.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000272993.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000272993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000272995.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000273002.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000273004.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000273004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000273007.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000273009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000273015.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000273015.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000273017.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000273019.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000273019.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Bosutinib |
ENSG00000273026.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bosutinib |
ENSG00000273038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000273056.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000273061.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000273076.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000273081.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000273100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000273139.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000273145.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000273156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000273162.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000273165.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000273174.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000273175.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000273181.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000273181.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000273183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bosutinib |
ENSG00000273188.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bosutinib |
ENSG00000273218.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000273245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bosutinib |
ENSG00000273248.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000273253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000273265.1 |
Predicted lncRNA |
Multiple myeloma plasma cell leukemia |
|
| Bosutinib |
ENSG00000273267.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000273287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000273289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000273290.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000273295.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000273301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000273306.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000273306.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000273307.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000273341.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000273342.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bosutinib |
ENSG00000273353.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000273355.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000273374.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000273381.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bosutinib |
ENSG00000273384.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bosutinib |
ENSG00000273416.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Bosutinib |
ENSG00000273424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bosutinib |
ENSG00000273424.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bosutinib |
ENSG00000273454.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Bosutinib |
ENSG00000273454.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bosutinib |
ENSG00000273474.1 |
Predicted lncRNA |
Sarcoma |
|
| Bosutinib |
ENSG00000273476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bosutinib |
ENSG00000273492.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|